GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)

NCT07058298 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Generalized Myasthenia Gravis (gMG)

Interventions

DRUG: GC012F injection

Sponsor

Daishi Tian

Collaborators

[object Object]